Related Experiment Video
Updated: May 3, 2026
08:56
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.5K
[Medicinal rate control in atrial fibrillation]
1Medizinische Klinik I, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Deutschland, michael.nabauer@med.uni-muenchen.de.
Herzschrittmachertherapie & Elektrophysiologie
|February 18, 2014
Summary
Atrial fibrillation management focuses on controlling heart rate for symptom relief and preventing complications. Treatment decisions are individualized based on patient factors, with rhythm control often preferred for younger individuals.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Context:
- Atrial fibrillation (AF) is the most prevalent persistent cardiac arrhythmia.
- AF often leads to rapid ventricular rates, causing significant clinical symptoms and hemodynamic instability.
- Acute control of the ventricular rate is crucial for stabilization and symptom improvement.
Purpose:
- To outline strategies for managing atrial fibrillation, focusing on rate control.
- To discuss individualized long-term treatment decisions for atrial fibrillation.
- To highlight factors influencing the choice between rate and rhythm control strategies.
Summary:
- The primary goal in atrial fibrillation management is symptom minimization and complication prevention.
- Rate control strategies, using beta-blockers, calcium antagonists, or digoxin, are key for managing rapid ventricular response.
- Individualized treatment considers patient age, sinus rhythm maintenance potential, drug tolerance, and comorbidities, with rhythm control favored for younger patients.
Impact:
- Effective atrial fibrillation management improves patient quality of life and reduces the risk of adverse cardiovascular events.
- Individualized treatment selection optimizes therapeutic outcomes and minimizes treatment-related risks.
- Understanding treatment nuances aids clinicians in making informed decisions for diverse patient populations.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.8K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.8K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
01:29Disturbances in Heart Rhythm
5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686